Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $2.46 Million - $2.99 Million
15,000 Added 84.75%
32,700 $6.46 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $417,933 - $488,052
2,700 Added 18.0%
17,700 $3.04 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $2.4 Million - $2.73 Million
15,000 New
15,000 $2.73 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $3.73 Million - $4.3 Million
25,800 Added 48.04%
79,500 $12.7 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $13.3 Million - $16 Million
-96,300 Reduced 64.2%
53,700 $8.68 Million
Q3 2022

Nov 15, 2022

SELL
$134.21 - $153.93 $13.4 Million - $15.4 Million
-100,000 Reduced 40.0%
150,000 $20.2 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $472 Million - $600 Million
-3,427,200 Reduced 93.2%
250,000 $38.4 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $354 Million - $448 Million
3,297,200 Added 867.68%
3,677,200 $498 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $37.2 Million - $42.3 Million
350,000 Added 1166.67%
380,000 $41.4 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $1.55 Million - $2.35 Million
-24,000 Reduced 44.44%
30,000 $2.29 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $1.88 Million - $2.35 Million
-26,000 Reduced 32.5%
54,000 $4.78 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $21 Million - $25.2 Million
-333,200 Reduced 80.64%
80,000 $5.86 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $10.6 Million - $14.2 Million
-115,000 Reduced 21.77%
413,200 $39.1 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $38 Million - $50.9 Million
413,200 Added 359.3%
528,200 $52.1 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $4.34 Million - $4.76 Million
48,500 Added 72.93%
115,000 $13 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $4.65 Million - $5.93 Million
66,500
66,500 $5.91 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.